Selected research
Industry Growth & Trends
Global Parasitic Diseases Therapeutic Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Parasitic Diseases Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Parasitic Diseases Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Parasitic Diseases Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Parasitic Diseases Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Parasitic Diseases Therapeutic market include Pfizer, GlaxoSmithKline, Bayer, Sanaria and F. Hoffmann-La Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Parasitic Diseases Therapeutic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Parasitic Diseases Therapeutic market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Parasitic Diseases Therapeutic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Parasitic Diseases Therapeutic.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Parasitic Diseases Therapeutic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Parasitic Diseases Therapeutic Market by Company
Pfizer
GlaxoSmithKline
Bayer
Sanaria
F. Hoffmann-La Roche
Parasitic Diseases Therapeutic Segment by Type
Acaricide
Insect Repellent
Peptides Medicine
Other
Parasitic Diseases Therapeutic Segment by Application
Commercial
Household
Parasitic Diseases Therapeutic Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parasitic Diseases Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parasitic Diseases Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parasitic Diseases Therapeutic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Parasitic Diseases Therapeutic companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Acaricide
- Insect Repellent
- Peptides Medicine
- Other
Applications
- Commercial
- Household
Companies covered
- Pfizer
- GlaxoSmithKline
- Bayer
- Sanaria
- F. Hoffmann-La Roche
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Parasitic Diseases Therapeutic Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Parasitic Diseases Therapeutic Market Size by Region (2021-2032)
- 1.4.1 Global Parasitic Diseases Therapeutic Market Size by Region (2021-2026)
- 1.4.2 Global Parasitic Diseases Therapeutic Market Size by Region (2027-2032)
- 1.5 Key Regions Parasitic Diseases Therapeutic Market Size (2021-2032)
- 1.5.1 North America Parasitic Diseases Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Parasitic Diseases Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.4 South America Parasitic Diseases Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Parasitic Diseases Therapeutic Market Size Growth Rate (2021-2032)
2 Parasitic Diseases Therapeutic Market by Type
- 2.1 Type Introduction
- 2.1.1 Acaricide
- 2.1.2 Insect Repellent
- 2.1.3 Peptides Medicine
- 2.1.4 Other
- 2.2 Global Parasitic Diseases Therapeutic Market Size by Type
- 2.2.1 Global Parasitic Diseases Therapeutic Market Size Overview by Type (2021-2032)
- 2.2.2 Global Parasitic Diseases Therapeutic Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Parasitic Diseases Therapeutic Market Size Forecasted by Type (2027-2032)
- 2.3 Global Parasitic Diseases Therapeutic Market Size by Regions
- 2.3.1 North America Parasitic Diseases Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Parasitic Diseases Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Parasitic Diseases Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Parasitic Diseases Therapeutic Market Size Breakdown by Type (2021-2026)
3 Parasitic Diseases Therapeutic Market by Application
- 3.1 Type Introduction
- 3.1.1 Commercial
- 3.1.2 Household
- 3.2 Global Parasitic Diseases Therapeutic Market Size by Application
- 3.2.1 Global Parasitic Diseases Therapeutic Market Size Overview by Application (2021-2032)
- 3.2.2 Global Parasitic Diseases Therapeutic Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Parasitic Diseases Therapeutic Market Size Forecasted by Application (2027-2032)
- 3.3 Global Parasitic Diseases Therapeutic Market Size by Regions
- 3.3.1 North America Parasitic Diseases Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Parasitic Diseases Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Parasitic Diseases Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Parasitic Diseases Therapeutic Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Parasitic Diseases Therapeutic Industry Trends
- 4.2 Parasitic Diseases Therapeutic Industry Drivers
- 4.3 Parasitic Diseases Therapeutic Industry Opportunities and Challenges
- 4.4 Parasitic Diseases Therapeutic Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Parasitic Diseases Therapeutic Revenue (2021-2026)
- 5.2 Global Parasitic Diseases Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Parasitic Diseases Therapeutic Key Company Headquarters & Area Served
- 5.4 Global Parasitic Diseases Therapeutic Company, Product Type & Application
- 5.5 Global Parasitic Diseases Therapeutic Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Parasitic Diseases Therapeutic Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Parasitic Diseases Therapeutic Players Market Share by Revenue in 2025
- 5.6.3 2025 Parasitic Diseases Therapeutic Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Pfizer
- 6.1.1 Pfizer Company Information
- 6.1.2 Pfizer Business Overview
- 6.1.3 Pfizer Parasitic Diseases Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Pfizer Parasitic Diseases Therapeutic Product Portfolio
- 6.1.5 Pfizer Recent Developments
- 6.2 GlaxoSmithKline
- 6.2.1 GlaxoSmithKline Company Information
- 6.2.2 GlaxoSmithKline Business Overview
- 6.2.3 GlaxoSmithKline Parasitic Diseases Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GlaxoSmithKline Parasitic Diseases Therapeutic Product Portfolio
- 6.2.5 GlaxoSmithKline Recent Developments
- 6.3 Bayer
- 6.3.1 Bayer Company Information
- 6.3.2 Bayer Business Overview
- 6.3.3 Bayer Parasitic Diseases Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Bayer Parasitic Diseases Therapeutic Product Portfolio
- 6.3.5 Bayer Recent Developments
- 6.4 Sanaria
- 6.4.1 Sanaria Company Information
- 6.4.2 Sanaria Business Overview
- 6.4.3 Sanaria Parasitic Diseases Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sanaria Parasitic Diseases Therapeutic Product Portfolio
- 6.4.5 Sanaria Recent Developments
- 6.5 F. Hoffmann-La Roche
- 6.5.1 F. Hoffmann-La Roche Company Information
- 6.5.2 F. Hoffmann-La Roche Business Overview
- 6.5.3 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 F. Hoffmann-La Roche Parasitic Diseases Therapeutic Product Portfolio
- 6.5.5 F. Hoffmann-La Roche Recent Developments
7 North America
- 7.1 North America Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Parasitic Diseases Therapeutic Market Size by Country (2021-2026)
- 7.3 North America Parasitic Diseases Therapeutic Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Parasitic Diseases Therapeutic Market Size by Country (2021-2026)
- 8.3 Europe Parasitic Diseases Therapeutic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Parasitic Diseases Therapeutic Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Parasitic Diseases Therapeutic Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Parasitic Diseases Therapeutic Market Size by Country (2021-2026)
- 10.3 South America Parasitic Diseases Therapeutic Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Parasitic Diseases Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Parasitic Diseases Therapeutic Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Parasitic Diseases Therapeutic Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst